Study Analyzes Use of Circulating Tumor Cells as Prognostic Marker in Ovarian Cancer

Study Analyzes Use of Circulating Tumor Cells as Prognostic Marker in Ovarian Cancer
Most women with epithelial ovarian cancer have circulating tumor cells, and among those who recently received their cancer diagnosis, the more such cells they had, the shorter their survival times, according to new research. While the findings provide useful tool for a clinical setting, researchers urge larger studies to validate the results and examine if

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *